In vivo CAR T-cell therapies promise to revolutionize cancer treatment, enhancing access and reducing costs while addressing ...

For savvy investors looking for long-term businesses that not only dominate their industries today but also have the ...

Eli Lilly's Mounjaro and Zepbound drove Q2 2025 revenue up 38% and EPS up 92% YoY. Read why LLY stock's recent 20% pullback ...

In May, it announced it would acquire SiteOne Therapeutics, a drugmaker with a promising investigational medicine for pain.

Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q2 2025 Earnings Conference Call. [Operator ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

The state of Wisconsin is offering up to $100 million in performance-based tax incentives to support pharmaceutical giant Eli Lilly’s $4 billion investment in Kenosha County, Gov. Tony Evers ...

Earnings season marches on, with results from Eli Lilly, Walt Disney and McDonald’s among this week's highlights, along with President Trump's new tariff-hike deadline for many countries. Trump ...

Drugmakers Novo Nordisk and Eli Lilly have sued multiple times to stop this, though the compounders are still out there. Analysts say the companies might have to lower prices to compete.

Lawsuits from at least 26 patients have been filed in Marion County against Eli Lilly and Co. for its marketing of the drugs GLP-1 Trulicity and Mounjaro, claiming the treatments for diabetes and ...

Eli Lilly and Company, a pharmaceutical manufacturing facility, will be receiving up to $100 million in performance-based state tax credits for its $4 billion investment in Wisconsin.